Login / Signup

ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.

Isabelle VeysCatalin-Florin PopRomain BarbieuxMichel MoreauDanielle NotermanFilip De NeubourgJean-Marie NogaretGabriel LiberaleDenis LarsimontPierre Bourgeois
Published in: PloS one (2018)
These first observations indicate that ex vivo ICG-FI is sensitive but not sufficiently specific to discriminate between benign breast tissue and malignant residual tissue. Nevertheless, its negative predictive value seems sufficiently accurate to exclude the presence of residual breast tumor tissue on the operative specimen of patients treated by NACT, representing a potential tool to assist pathologists in the assessment of breast surgical specimens.
Keyphrases